Advanced Search
Display options
Filter resources
Text Availability
Article type
Publication date
Species
Language
Sex
Age
Showing 1 to 12 of 13 entries
Sorted by: Best Match Show Resources per page
[No title available]

Soins. Gerontologie

Pamoukdjian F, Tine S, Aber M, Ferreira A, Sebbane G, Paillaud E.
PMID: 29530290
Soins Gerontol. 2018 Mar - Apr;23(130):45-46. doi: 10.1016/j.sger.2018.01.009.

No abstract available.

Cite
Pamoukdjian F, Tine S, Aber M, et al. 32. Un myxofibrosarcome de haut grade de la cuisse chez une patiente âgée. . Soins Gerontol. 2018;23(130):45-46doi: 10.1016/j.sger.2018.01.009.
Pamoukdjian, F., Tine, S., Aber, M., Ferreira, A., Sebbane, G., & Paillaud, E. (2018). 32. Un myxofibrosarcome de haut grade de la cuisse chez une patiente âgée. . Soins. Gerontologie, 23(130), 45-46. https://doi.org/10.1016/j.sger.2018.01.009
Pamoukdjian, Frédéric, et al. "32. Un myxofibrosarcome de haut grade de la cuisse chez une patiente âgée." . Soins. Gerontologie vol. 23,130 (2018): 45-46. doi: https://doi.org/10.1016/j.sger.2018.01.009
Pamoukdjian F, Tine S, Aber M, Ferreira A, Sebbane G, Paillaud E. 32. Un myxofibrosarcome de haut grade de la cuisse chez une patiente âgée. . Soins Gerontol. 2018 Mar - Apr;23(130):45-46. doi: 10.1016/j.sger.2018.01.009. French. PMID: 29530290.
Copy Download .nbib Format: NLM
Genomics of Clear-cell Renal Cell Carcinoma: A Systematic Review and Meta-analysis.

European urology

Bui TO, Dao VT, Nguyen VT, Feugeas JP, Pamoukdjian F, Bousquet G.
PMID: 34991918
Eur Urol. 2022 Jan 03; doi: 10.1016/j.eururo.2021.12.010. Epub 2022 Jan 03.

CONTEXT: Although antiangiogenic treatments and immunotherapies have significantly improved the prognosis of metastatic renal cell carcinoma (RCC), many patients will develop resistance, leading to treatment failure. Genetic tumor heterogeneity is a major cause of this resistance.OBJECTIVE: To perform a...

Cite
Bui TO, Dao VT, Nguyen VT, et al. Genomics of Clear-cell Renal Cell Carcinoma: A Systematic Review and Meta-analysis. Eur Urol. 2022;doi: 10.1016/j.eururo.2021.12.010.
Bui, T. O., Dao, V. T., Nguyen, V. T., Feugeas, J. P., Pamoukdjian, F., & Bousquet, G. (2022). Genomics of Clear-cell Renal Cell Carcinoma: A Systematic Review and Meta-analysis. European urology, . https://doi.org/10.1016/j.eururo.2021.12.010
Bui, Thi Oanh, et al. "Genomics of Clear-cell Renal Cell Carcinoma: A Systematic Review and Meta-analysis." European urology vol. (2022). doi: https://doi.org/10.1016/j.eururo.2021.12.010
Bui TO, Dao VT, Nguyen VT, Feugeas JP, Pamoukdjian F, Bousquet G. Genomics of Clear-cell Renal Cell Carcinoma: A Systematic Review and Meta-analysis. Eur Urol. 2022 Jan 03; doi: 10.1016/j.eururo.2021.12.010. Epub 2022 Jan 03. PMID: 34991918.
Copy Download .nbib Format: NLM
Frailty Parameters, Morbidity and Mortality in Older Adults with Cancer: A Structural Equation Modelling Approach Based on the Fried Phenotype.

Journal of clinical medicine

Pamoukdjian F, Laurent M, Martinez-Tapia C, Rolland Y, Paillaud E, Canoui-Poitrine F.
PMID: 32545298
J Clin Med. 2020 Jun 11;9(6). doi: 10.3390/jcm9061826.

BACKGROUND: to distinguish direct and indirect pathways to frailty phenotype, and quantify associations between two frailty components (i.e., sarcopenia and cachexia) regarding mortality and morbidity in older adults with cancer.METHODS: all consecutive older outpatients with cancer were included in...

Cite
Pamoukdjian F, Laurent M, Martinez-Tapia C, et al. Frailty Parameters, Morbidity and Mortality in Older Adults with Cancer: A Structural Equation Modelling Approach Based on the Fried Phenotype. J Clin Med. 2020;9(6)doi: 10.3390/jcm9061826.
Pamoukdjian, F., Laurent, M., Martinez-Tapia, C., Rolland, Y., Paillaud, E., & Canoui-Poitrine, F. (2020). Frailty Parameters, Morbidity and Mortality in Older Adults with Cancer: A Structural Equation Modelling Approach Based on the Fried Phenotype. Journal of clinical medicine, 9(6), . https://doi.org/10.3390/jcm9061826
Pamoukdjian, Frederic, et al. "Frailty Parameters, Morbidity and Mortality in Older Adults with Cancer: A Structural Equation Modelling Approach Based on the Fried Phenotype." Journal of clinical medicine vol. 9,6 (2020). doi: https://doi.org/10.3390/jcm9061826
Pamoukdjian F, Laurent M, Martinez-Tapia C, Rolland Y, Paillaud E, Canoui-Poitrine F. Frailty Parameters, Morbidity and Mortality in Older Adults with Cancer: A Structural Equation Modelling Approach Based on the Fried Phenotype. J Clin Med. 2020 Jun 11;9(6). doi: 10.3390/jcm9061826. PMID: 32545298; PMCID: PMC7356550.
Copy Download .nbib Format: NLM
The obesity paradox for mid- and long-term mortality in older cancer patients: a prospective multicenter cohort study.

The American journal of clinical nutrition

Martinez-Tapia C, Diot T, Oubaya N, Paillaud E, Poisson J, Gisselbrecht M, Morisset L, Caillet P, Baudin A, Pamoukdjian F, Broussier A, Bastuji-Garin S, Laurent M, Canouï-Poitrine F.
PMID: 32889525
Am J Clin Nutr. 2020 Sep 05; doi: 10.1093/ajcn/nqaa238. Epub 2020 Sep 05.

BACKGROUND: Overweight and obesity are associated with adverse health outcomes. However, substantial literature suggests that they are associated with longer survival among older people. This "obesity paradox" remains controversial. In the context of cancer, the association between overweight/obesity and...

Cite
Martinez-Tapia C, Diot T, Oubaya N, et al. The obesity paradox for mid- and long-term mortality in older cancer patients: a prospective multicenter cohort study. Am J Clin Nutr. 2020;doi: 10.1093/ajcn/nqaa238.
Martinez-Tapia, C., Diot, T., Oubaya, N., Paillaud, E., Poisson, J., Gisselbrecht, M., Morisset, L., Caillet, P., Baudin, A., Pamoukdjian, F., Broussier, A., Bastuji-Garin, S., Laurent, M., & Canouï-Poitrine, F. (2020). The obesity paradox for mid- and long-term mortality in older cancer patients: a prospective multicenter cohort study. The American journal of clinical nutrition, . https://doi.org/10.1093/ajcn/nqaa238
Martinez-Tapia, Claudia, et al. "The obesity paradox for mid- and long-term mortality in older cancer patients: a prospective multicenter cohort study." The American journal of clinical nutrition vol. (2020). doi: https://doi.org/10.1093/ajcn/nqaa238
Martinez-Tapia C, Diot T, Oubaya N, Paillaud E, Poisson J, Gisselbrecht M, Morisset L, Caillet P, Baudin A, Pamoukdjian F, Broussier A, Bastuji-Garin S, Laurent M, Canouï-Poitrine F. The obesity paradox for mid- and long-term mortality in older cancer patients: a prospective multicenter cohort study. Am J Clin Nutr. 2020 Sep 05; doi: 10.1093/ajcn/nqaa238. Epub 2020 Sep 05. PMID: 32889525.
Copy Download .nbib Format: NLM
The Pre-Operative GRADE Score Is Associated with 5-Year Survival among Older Patients with Cancer Undergoing Surgery.

Cancers

Wind P, Ap Thomas Z, Laurent M, Aparicio T, Siebert M, Audureau E, Paillaud E, Bousquet G, Pamoukdjian F.
PMID: 35008281
Cancers (Basel). 2021 Dec 27;14(1). doi: 10.3390/cancers14010117.

We aimed to assess the prognostic value of the pre-operative GRADE score for long-term survival among older adults undergoing major surgery for digestive or non-breast gynaecological cancers. Between 2013 and 2019, 136 consecutive older adults with cancer were prospectively...

Cite
Wind P, Ap Thomas Z, Laurent M, et al. The Pre-Operative GRADE Score Is Associated with 5-Year Survival among Older Patients with Cancer Undergoing Surgery. Cancers (Basel). 2021;14(1)doi: 10.3390/cancers14010117.
Wind, P., Ap Thomas, Z., Laurent, M., Aparicio, T., Siebert, M., Audureau, E., Paillaud, E., Bousquet, G., & Pamoukdjian, F. (2021). The Pre-Operative GRADE Score Is Associated with 5-Year Survival among Older Patients with Cancer Undergoing Surgery. Cancers, 14(1), . https://doi.org/10.3390/cancers14010117
Wind, Philippe, et al. "The Pre-Operative GRADE Score Is Associated with 5-Year Survival among Older Patients with Cancer Undergoing Surgery." Cancers vol. 14,1 (2021). doi: https://doi.org/10.3390/cancers14010117
Wind P, Ap Thomas Z, Laurent M, Aparicio T, Siebert M, Audureau E, Paillaud E, Bousquet G, Pamoukdjian F. The Pre-Operative GRADE Score Is Associated with 5-Year Survival among Older Patients with Cancer Undergoing Surgery. Cancers (Basel). 2021 Dec 27;14(1). doi: 10.3390/cancers14010117. PMID: 35008281; PMCID: PMC8750490.
Copy Download .nbib Format: NLM
The Pre-Operative GRADE Score Is Associated with 5-Year Survival among Older Patients with Cancer Undergoing Surgery.

Cancers

Wind P, Ap Thomas Z, Laurent M, Aparicio T, Siebert M, Audureau E, Paillaud E, Bousquet G, Pamoukdjian F.
PMID: 35008281
Cancers (Basel). 2021 Dec 27;14(1). doi: 10.3390/cancers14010117.

We aimed to assess the prognostic value of the pre-operative GRADE score for long-term survival among older adults undergoing major surgery for digestive or non-breast gynaecological cancers. Between 2013 and 2019, 136 consecutive older adults with cancer were prospectively...

Cite
Wind P, Ap Thomas Z, Laurent M, et al. The Pre-Operative GRADE Score Is Associated with 5-Year Survival among Older Patients with Cancer Undergoing Surgery. Cancers (Basel). 2021;14(1)doi: 10.3390/cancers14010117.
Wind, P., Ap Thomas, Z., Laurent, M., Aparicio, T., Siebert, M., Audureau, E., Paillaud, E., Bousquet, G., & Pamoukdjian, F. (2021). The Pre-Operative GRADE Score Is Associated with 5-Year Survival among Older Patients with Cancer Undergoing Surgery. Cancers, 14(1), . https://doi.org/10.3390/cancers14010117
Wind, Philippe, et al. "The Pre-Operative GRADE Score Is Associated with 5-Year Survival among Older Patients with Cancer Undergoing Surgery." Cancers vol. 14,1 (2021). doi: https://doi.org/10.3390/cancers14010117
Wind P, Ap Thomas Z, Laurent M, Aparicio T, Siebert M, Audureau E, Paillaud E, Bousquet G, Pamoukdjian F. The Pre-Operative GRADE Score Is Associated with 5-Year Survival among Older Patients with Cancer Undergoing Surgery. Cancers (Basel). 2021 Dec 27;14(1). doi: 10.3390/cancers14010117. PMID: 35008281.
Copy Download .nbib Format: NLM
Diagnostic performance of gait speed, G8 and G8 modified indices to screen for vulnerability in older cancer patients: the prospective PF-EC cohort study.

Oncotarget

Pamoukdjian F, Canoui-Poitrine F, Longelin-Lombard C, Aparicio T, Ganne N, Wind P, Martinez-Tapia C, Audureau E, Sebbane G, Zelek L, Paillaud E.
PMID: 28881570
Oncotarget. 2017 Apr 21;8(31):50393-50402. doi: 10.18632/oncotarget.17361. eCollection 2017 Aug 01.

BACKGROUND: The diagnostic performance of tools used to screen vulnerability in older cancer patients varies widely. We assessed the diagnostic performance of gait speed (GS) for assessing vulnerability in such patients.METHODS: All consecutive outpatients 65 years and older were...

Cite
Pamoukdjian F, Canoui-Poitrine F, Longelin-Lombard C, et al. Diagnostic performance of gait speed, G8 and G8 modified indices to screen for vulnerability in older cancer patients: the prospective PF-EC cohort study. Oncotarget. 2017;8(31):50393-50402doi: 10.18632/oncotarget.17361.
Pamoukdjian, F., Canoui-Poitrine, F., Longelin-Lombard, C., Aparicio, T., Ganne, N., Wind, P., Martinez-Tapia, C., Audureau, E., Sebbane, G., Zelek, L., & Paillaud, E. (2017). Diagnostic performance of gait speed, G8 and G8 modified indices to screen for vulnerability in older cancer patients: the prospective PF-EC cohort study. Oncotarget, 8(31), 50393-50402. https://doi.org/10.18632/oncotarget.17361
Pamoukdjian, Frederic, et al. "Diagnostic performance of gait speed, G8 and G8 modified indices to screen for vulnerability in older cancer patients: the prospective PF-EC cohort study." Oncotarget vol. 8,31 (2017): 50393-50402. doi: https://doi.org/10.18632/oncotarget.17361
Pamoukdjian F, Canoui-Poitrine F, Longelin-Lombard C, Aparicio T, Ganne N, Wind P, Martinez-Tapia C, Audureau E, Sebbane G, Zelek L, Paillaud E. Diagnostic performance of gait speed, G8 and G8 modified indices to screen for vulnerability in older cancer patients: the prospective PF-EC cohort study. Oncotarget. 2017 Apr 21;8(31):50393-50402. doi: 10.18632/oncotarget.17361. eCollection 2017 Aug 01. PMID: 28881570; PMCID: PMC5584139.
Copy Download .nbib Format: NLM
[Sternal tumefaction].

La Revue de medecine interne

Pamoukdjian F, Al Nawakil C, Bouzouina L, Landré T, Sebbane G, Taleb C.
PMID: 28258865
Rev Med Interne. 2017 Oct;38(10):710-711. doi: 10.1016/j.revmed.2017.02.002. Epub 2017 Mar 01.

No abstract available.

Cite
Pamoukdjian F, Al Nawakil C, Bouzouina L, et al. Une tuméfaction sternale. [Sternal tumefaction]. Rev Med Interne. 2017;38(10):710-711doi: 10.1016/j.revmed.2017.02.002.
Pamoukdjian, F., Al Nawakil, C., Bouzouina, L., Landré, T., Sebbane, G., & Taleb, C. (2017). Une tuméfaction sternale. [Sternal tumefaction]. La Revue de medecine interne, 38(10), 710-711. https://doi.org/10.1016/j.revmed.2017.02.002
Pamoukdjian, F, et al. "Une tuméfaction sternale." [Sternal tumefaction]. La Revue de medecine interne vol. 38,10 (2017): 710-711. doi: https://doi.org/10.1016/j.revmed.2017.02.002
Pamoukdjian F, Al Nawakil C, Bouzouina L, Landré T, Sebbane G, Taleb C. Une tuméfaction sternale. [Sternal tumefaction]. Rev Med Interne. 2017 Oct;38(10):710-711. doi: 10.1016/j.revmed.2017.02.002. Epub 2017 Mar 01. French. PMID: 28258865.
Copy Download .nbib Format: NLM
Prevalence and prognostic impact of cachexia among older patients with cancer: a nationwide cross-sectional survey (NutriAgeCancer).

Journal of cachexia, sarcopenia and muscle

Poisson J, Martinez-Tapia C, Heitz D, Geiss R, Albrand G, Falandry C, Gisselbrecht M, Couderc AL, Boulahssass R, Liuu E, Boudou-Rouquette P, Chah Wakilian A, Gaxatte C, Pamoukdjian F, de Decker L, Antoine V, Cattenoz C, Solem-Laviec H, Guillem O, Medjenah H, Natella PA, Canouï-Poitrine F, Laurent M, Paillaud E.
PMID: 34519440
J Cachexia Sarcopenia Muscle. 2021 Dec;12(6):1477-1488. doi: 10.1002/jcsm.12776. Epub 2021 Sep 14.

BACKGROUND: Nutritional impairment is common in cancer patients and is associated with poor outcomes. Only few studies focused on cachexia. We assessed the prevalence of cachexia in older cancer patients, identified associated risk factors, and evaluated its impact on...

Cite
Poisson J, Martinez-Tapia C, Heitz D, et al. Prevalence and prognostic impact of cachexia among older patients with cancer: a nationwide cross-sectional survey (NutriAgeCancer). J Cachexia Sarcopenia Muscle. 2021;12(6):1477-1488doi: 10.1002/jcsm.12776.
Poisson, J., Martinez-Tapia, C., Heitz, D., Geiss, R., Albrand, G., Falandry, C., Gisselbrecht, M., Couderc, A. L., Boulahssass, R., Liuu, E., Boudou-Rouquette, P., Chah Wakilian, A., Gaxatte, C., Pamoukdjian, F., de Decker, L., Antoine, V., Cattenoz, C., Solem-Laviec, H., Guillem, O., Medjenah, H., Natella, P. A., Canouï-Poitrine, F., Laurent, M., & Paillaud, E. (2021). Prevalence and prognostic impact of cachexia among older patients with cancer: a nationwide cross-sectional survey (NutriAgeCancer). Journal of cachexia, sarcopenia and muscle, 12(6), 1477-1488. https://doi.org/10.1002/jcsm.12776
Poisson, Johanne, et al. "Prevalence and prognostic impact of cachexia among older patients with cancer: a nationwide cross-sectional survey (NutriAgeCancer)." Journal of cachexia, sarcopenia and muscle vol. 12,6 (2021): 1477-1488. doi: https://doi.org/10.1002/jcsm.12776
Poisson J, Martinez-Tapia C, Heitz D, Geiss R, Albrand G, Falandry C, Gisselbrecht M, Couderc AL, Boulahssass R, Liuu E, Boudou-Rouquette P, Chah Wakilian A, Gaxatte C, Pamoukdjian F, de Decker L, Antoine V, Cattenoz C, Solem-Laviec H, Guillem O, Medjenah H, Natella PA, Canouï-Poitrine F, Laurent M, Paillaud E. Prevalence and prognostic impact of cachexia among older patients with cancer: a nationwide cross-sectional survey (NutriAgeCancer). J Cachexia Sarcopenia Muscle. 2021 Dec;12(6):1477-1488. doi: 10.1002/jcsm.12776. Epub 2021 Sep 14. PMID: 34519440.
Copy Download .nbib Format: NLM
Prognostic Value of Prospective Longitudinal CRP to Albumin Ratio among Older Outpatients with Cancer.

Cancers

Burgassi F, Paillaud E, Poisson J, Bousquet G, Pamoukdjian F.
PMID: 34830936
Cancers (Basel). 2021 Nov 18;13(22). doi: 10.3390/cancers13225782.

The prognostic value of the CRP to albumin ratio (CAR) among older adults with cancer is not known. Six hundred and three older outpatients with cancer and undergoing geriatric assessment before therapeutic decisions were prospectively recruited from the PF-EC...

Cite
Burgassi F, Paillaud E, Poisson J, et al. Prognostic Value of Prospective Longitudinal CRP to Albumin Ratio among Older Outpatients with Cancer. Cancers (Basel). 2021;13(22)doi: 10.3390/cancers13225782.
Burgassi, F., Paillaud, E., Poisson, J., Bousquet, G., & Pamoukdjian, F. (2021). Prognostic Value of Prospective Longitudinal CRP to Albumin Ratio among Older Outpatients with Cancer. Cancers, 13(22), . https://doi.org/10.3390/cancers13225782
Burgassi, Fiamma, et al. "Prognostic Value of Prospective Longitudinal CRP to Albumin Ratio among Older Outpatients with Cancer." Cancers vol. 13,22 (2021). doi: https://doi.org/10.3390/cancers13225782
Burgassi F, Paillaud E, Poisson J, Bousquet G, Pamoukdjian F. Prognostic Value of Prospective Longitudinal CRP to Albumin Ratio among Older Outpatients with Cancer. Cancers (Basel). 2021 Nov 18;13(22). doi: 10.3390/cancers13225782. PMID: 34830936; PMCID: PMC8616216.
Copy Download .nbib Format: NLM
Prevalence and prognostic impact of cachexia among older patients with cancer: a nationwide cross-sectional survey (NutriAgeCancer).

Journal of cachexia, sarcopenia and muscle

Poisson J, Martinez-Tapia C, Heitz D, Geiss R, Albrand G, Falandry C, Gisselbrecht M, Couderc AL, Boulahssass R, Liuu E, Boudou-Rouquette P, Chah Wakilian A, Gaxatte C, Pamoukdjian F, de Decker L, Antoine V, Cattenoz C, Solem-Laviec H, Guillem O, Medjenah H, Natella PA, Canouï-Poitrine F, Laurent M, Paillaud E.
PMID: 34519440
J Cachexia Sarcopenia Muscle. 2021 Dec;12(6):1477-1488. doi: 10.1002/jcsm.12776. Epub 2021 Sep 14.

BACKGROUND: Nutritional impairment is common in cancer patients and is associated with poor outcomes. Only few studies focused on cachexia. We assessed the prevalence of cachexia in older cancer patients, identified associated risk factors, and evaluated its impact on...

Cite
Poisson J, Martinez-Tapia C, Heitz D, et al. Prevalence and prognostic impact of cachexia among older patients with cancer: a nationwide cross-sectional survey (NutriAgeCancer). J Cachexia Sarcopenia Muscle. 2021;12(6):1477-1488doi: 10.1002/jcsm.12776.
Poisson, J., Martinez-Tapia, C., Heitz, D., Geiss, R., Albrand, G., Falandry, C., Gisselbrecht, M., Couderc, A. L., Boulahssass, R., Liuu, E., Boudou-Rouquette, P., Chah Wakilian, A., Gaxatte, C., Pamoukdjian, F., de Decker, L., Antoine, V., Cattenoz, C., Solem-Laviec, H., Guillem, O., Medjenah, H., Natella, P. A., Canouï-Poitrine, F., Laurent, M., & Paillaud, E. (2021). Prevalence and prognostic impact of cachexia among older patients with cancer: a nationwide cross-sectional survey (NutriAgeCancer). Journal of cachexia, sarcopenia and muscle, 12(6), 1477-1488. https://doi.org/10.1002/jcsm.12776
Poisson, Johanne, et al. "Prevalence and prognostic impact of cachexia among older patients with cancer: a nationwide cross-sectional survey (NutriAgeCancer)." Journal of cachexia, sarcopenia and muscle vol. 12,6 (2021): 1477-1488. doi: https://doi.org/10.1002/jcsm.12776
Poisson J, Martinez-Tapia C, Heitz D, Geiss R, Albrand G, Falandry C, Gisselbrecht M, Couderc AL, Boulahssass R, Liuu E, Boudou-Rouquette P, Chah Wakilian A, Gaxatte C, Pamoukdjian F, de Decker L, Antoine V, Cattenoz C, Solem-Laviec H, Guillem O, Medjenah H, Natella PA, Canouï-Poitrine F, Laurent M, Paillaud E. Prevalence and prognostic impact of cachexia among older patients with cancer: a nationwide cross-sectional survey (NutriAgeCancer). J Cachexia Sarcopenia Muscle. 2021 Dec;12(6):1477-1488. doi: 10.1002/jcsm.12776. Epub 2021 Sep 14. PMID: 34519440; PMCID: PMC8718093.
Copy Download .nbib Format: NLM
Increased risk of brain metastases among patients with melanoma and PROM2 expression in metastatic lymph nodes.

Clinical and translational medicine

Nguyen TT, Gapihan G, Tetu P, Pamoukdjian F, El Bouchtaoui M, Lebœuf C, Feugeas JP, Paris J, Baroudjian B, Delyon J, Mourah S, Lebbé C, Janin A, Bousquet G, Battistella M.
PMID: 33377645
Clin Transl Med. 2020 Dec;10(8):e198. doi: 10.1002/ctm2.198.

No abstract available.

Cite
Nguyen TT, Gapihan G, Tetu P, et al. Increased risk of brain metastases among patients with melanoma and PROM2 expression in metastatic lymph nodes. Clin Transl Med. 2020;10(8):e198doi: 10.1002/ctm2.198.
Nguyen, T. T., Gapihan, G., Tetu, P., Pamoukdjian, F., El Bouchtaoui, M., Lebœuf, C., Feugeas, J. P., Paris, J., Baroudjian, B., Delyon, J., Mourah, S., Lebbé, C., Janin, A., Bousquet, G., & Battistella, M. (2020). Increased risk of brain metastases among patients with melanoma and PROM2 expression in metastatic lymph nodes. Clinical and translational medicine, 10(8), e198. https://doi.org/10.1002/ctm2.198
Nguyen, Thuy Thi, et al. "Increased risk of brain metastases among patients with melanoma and PROM2 expression in metastatic lymph nodes." Clinical and translational medicine vol. 10,8 (2020): e198. doi: https://doi.org/10.1002/ctm2.198
Nguyen TT, Gapihan G, Tetu P, Pamoukdjian F, El Bouchtaoui M, Lebœuf C, Feugeas JP, Paris J, Baroudjian B, Delyon J, Mourah S, Lebbé C, Janin A, Bousquet G, Battistella M. Increased risk of brain metastases among patients with melanoma and PROM2 expression in metastatic lymph nodes. Clin Transl Med. 2020 Dec;10(8):e198. doi: 10.1002/ctm2.198. PMID: 33377645; PMCID: PMC7711084.
Copy Download .nbib Format: NLM
Showing 1 to 12 of 13 entries